September 7-8, 2019 • New York, NY Reserve Your Seat
January 17-20, 2020 | Orlando, FL Reserve Your Seat
CURRENT ISSUE HIGHLIGHTS
What Is “PFE”? It May Just Be Time You Found Out….
With all the literature and research we have on acne and rosacea, there are still many unanswered questions. Over time, as we uncover more informatio...
read moreThe Use of Oral Antibiotics in the Management of Rosacea
Rosacea is a common chronic inflammatory facial dermatosis. The prevalence ranges from 1-20% of the population depending on the demogra...
read morePatient-Reported Outcomes in Acne Patients With Skin of Color Using Adapalene 0.3%-Benzoyl Peroxide 2.5%: A Prospective Real-World Study
Acne vulgaris is a common chronic disorder, constituting the eighth most prevalent disease with an estimated 9% global prevalence. 1 A...
read moreSafety and Effectiveness of Microfocused Ultrasound for Treating Erythematotelangiectatic Rosacea
Rosacea is a chronic, cutaneous inflammatory syndrome that most commonly affects the convexities of the central face, including the che...
read moreClinical Validation of the Surface Volume Coefficient for Minimally Invasive Treatment of the Temple
Facial aging is a multi-factorial process resulting in a range of physiologic and morphologic changes in both the hard and soft tissues...
read moreA Phase 2, Multicenter, Double-Blind, Randomized, Vehicle-Controlled Clinical Study to Compare the Safety and Efficacy of a Novel Tazarotene 0.045% Lotion and Tazarotene 0.1% Cream in the Treatment of Moderate-to-Severe Acne Vulgaris
Topical retinoids (eg, tazarotene, tretinoin, adapalene) have played an important role in the management of acne vulgaris (acne). They ...
read moreUpdate on the Treatment of Scars
Treatment of scars remains a persisting challenge. Scarring can be classified as a fibrous tissue disorder, which can occur as a conseq...
read moreValidation of Botanical Treatment Efficiency for Adults and Children Suffering from Mild to Moderate Atopic Dermatitis
Atopic dermatitis (AD) is a common chronic inflammatory skin disease with a lifetime prevalence of 10-20% in children and 1-3% in adult...
read morePharmacokinetic Profile, Safety, and Tolerability of Clascoterone (Cortexolone 17-alpha propionate, CB-03-01) Topical Cream, 1% in Subjects With Acne Vulgaris: An Open-Label Phase 2a Study
Acne is a chronic inflammatory skin condition of the pilosebaceous glands that typically begins at puberty and may continue through adu...
read moreA Phase 2b, Randomized, Double-Blind Vehicle Controlled, Dose Escalation Study Evaluating Clascoterone 0.1%, 0.5%, and 1% Topical Cream in Subjects With Facial Acne
Acne vulgaris is a chronic inflammatory skin condition characterized by obstruction and inflammation of the pilosebaceous units within ...
read moreDNA Repair Enzyme Containing Lip Balm for the Treatment of Actinic Cheilitis: A Pilot Study
Actinic cheilitis (AC), also known as actinic keratosis (AK) of the lips, is a common lesion of the lower lip caused by chronic exposur...
read moreConnecting the Dots: From Skin Barrier Dysfunction to Allergic Sensitization, and the Role of Moisturizers in Repairing the Skin Barrier
The skin is one of the largest immunologic organs in the body and a continuous target for allergic and immunologic responses. Rising in...
read more
SURVEY
Tell us what you think: Take the survey below to help us
improve your JDDonline experience.
Take the Survey!
